Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. - Murphy,G.P.; Tjoa,B.A.; Simmons,S.J.; Jarisch,J.; Bowes,V.A.; Ragde,H.; Rogers,M.; Elgamal,A.; Kenny,G.M.; Cobb,O.E.; Ireton,R.C.; Troychak,M.J.; et al. (Prostate, 1999)